Sanara Capital
Overview
Sanara Capital is a dedicated Health-Tech fund, established in 2023, specializing in Digital Health, Bio-Convergence, and Medical Devices. Sanara Capital is focused on A & B financing rounds of Israeli related startups in Israel and abroad. We are a follow-on fund of Sanara Ventures, a seed-stage investment platform, established in 2015, and backed by industry leaders Philips and Teva, with nearly 20 active portfolio companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Ukko | Jan 2026 | Series C | Co-investor |
| TailorMed | Nov 2024 | Series C | - |
| CVAid Medical | Feb 2022 | Series A | Co-investor |
Key People
Daniel Kahn
European Venture Partner
Jan Kimpen
Venture Partner
Eran Toledo
Chief Technology Officer And Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Sanara Capital based?
Sanara Capital is headquartered in Ra'anana, Central District, Israel.
When was Sanara Capital founded?
Sanara Capital was founded in 2021.
How many portfolio companies does Sanara Capital have?
Sanara Capital has 3 portfolio companies in Caplight's dataset.
What are some companies in Sanara Capital's portfolio?
Portfolio companies visible on Caplight include Ukko, TailorMed, CVAid Medical.
What was Sanara Capital's most recent investment shown here?
Sanara Capital's most recent investment in this portfolio sample was in Ukko in 2026.
What sectors does Sanara Capital focus on?
Sanara Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software.
What company stages does Sanara Capital focus on?
Sanara Capital typically invests at the Mid stage.
What is Sanara Capital's AUM?
Sanara Capital's assets under management are estimated between $50.0M and $100.0M.